Search
for
Sort by
Research 31–60 of 1000+
- Finasteride-Induced Gynecomastia in a 62-Year-Old Man
- A randomized double blind study of the effect of finasteride on hair growth in male patients of androgenetic alopecia
- Lack of evidence of a role for the neurosteroid allopregnanolone in ethanol-induced reward and c-fos expression in DBA/2 mice
- Hormonal manipulation of benign prostatic hyperplasia
- Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics
- Current treatment of BPH
- HAIR REGROWTH
- Developmental Mechanisms Controlling Cell Fate, Evolution of
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Finasteride in the Treatment of Hirsutism
- Benzo[<i>c</i>]quinolizin-3-ones: A Novel Class of Potent and Selective Nonsteroidal Inhibitors of Human Steroid 5α-Reductase 1
- Effect of C-ring modifications in benzo[c]quinolizin-3-ones, new selective inhibitors of human 5α-reductase 1
- Determination of finasteride in the tablet form by liquid chromatography and its analytical method validation
- High-performance liquid chromatographic method for the determination of finasteride in human plasma at therapeutic doses
- Anti-androgenic curcumin analogues as steroid 5-alpha reductase inhibitors
- Steroid 5α-reductase inhibition by polymethoxyflavones
- Clinical use of 5α-reductase inhibitors
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- DEVELOPING AND VALIDATING AN HPLC METHOD TO QUANTIFY SIMULTANEOUSLY DUTASTERIDE AND THEIR RELATED MOLECULES (DUTASTERIDE ACID, 2,5 BIS- (TRI FLUORO METHYL)-ANILINE AND DUTASTERIDE 17 α-EPIMER) IN CAPSULES
- Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Targets to treat androgen excess in polycystic ovary syndrome
- Development of Liposomal Systems of Finasteride for Topical Applications: Design, Characterization, and In Vitro Evaluation
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors.
- Solubilities of Flutamide, Dutasteride, and Finasteride as Antiandrogenic Agents, in Supercritical Carbon Dioxide: Measurement and Correlation
- Steroid Hormones
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- In Search of Predictive Models for Inhibitors of 5-alpha Reductase 2 Based on the Integration of Bioactivity and Molecular Descriptors Data.